U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734415) titled 'Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis' on June 11.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)
Study Start Date: June 05
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Atopic Dermatitis Eczema
Eczema
Intervention:
DRUG: IMG-007
Participants will receive IMG-007 subcutaneously.
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Inmagene LLC
Published by HT Digital Content Services with permission from Health D...